Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):535–541. doi: 10.1111/j.1476-5381.1992.tb09015.x

Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem.

F Sannajust 1, C Barrès 1, E Koenig-Bérard 1, J Sassard 1
PMCID: PMC1908468  PMID: 1352718

Abstract

1. To determine the site of action of rilmenidine, we examined its effets on arterial blood pressure (BP), heart rate (HR) and postganglionic renal sympathetic nerve activity (RSNA) after intracerebroventricular (i.c.v.) administration (300 micrograms kg-1), in groups (all n = 6) of conscious and freely moving, pentobarbitone-anaesthetized and pentobarbitone-anaesthetized and spinally transected, fifteen week-old male spontaneously hypertensive rats (SHRs). 2. In conscious SHRs, which exhibited a low sympathetic nerve activity (RSNA: 3.4 +/- 0.9 muV), rilmenidine was inactive on systolic BP (SBP), diastolic BP (DBP), HR and RSNA. 3. In intact pentobarbitone-anaesthetized SHRs, which exhibited an elevated sympathetic nerve activity (RSNA: 10.6 +/- 0.9 muV), rilmenidine exerted potent antihypertensive (delta SBP: -37 +/- 4%; delta DBP: -43 +/- 6%), bradycardic (delta HR: -32 +/- 3%) and sympathoinhibitory (delta RSNA: -68 +/- 9%) activities. 4. In pentobarbitone-anaesthetized SHRs with cervical spinal cord transection, BP was markedly decreased and sympathetic nerve activity (RSNA: 10.3 +/- 3.1 muV) returned to the level observed in conscious SHRs (RSNA: 3.6 +/- 0.5 muV). In these conditions, rilmenidine remained sympathoinhibitory (delta RSNA: -74 +/- 5%). 5. In conclusion, we have shown that pentobarbitone-anaesthesia enhances the peripheral sympathetic tone by a central action, as the spinal cord transection allows RSNA to return to normal levels and that, spinal or ganglionic structures could be a major site of the sympathoinhibitory action of rilmenidine.

Full text

PDF
535

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonham A. C., Trapani A. J., Portis L. R., Brody M. J. Studies on the mechanism of the central antihypertensive effect of guanabenz and clonidine. J Hypertens Suppl. 1984 Dec;2(3):S543–S546. [PubMed] [Google Scholar]
  2. Bousquet P., Feldman J., Bloch R., Schwartz J. The nucleus reticularis lateralis: a region highly sensitive to clonidine. Eur J Pharmacol. 1981 Jan 29;69(3):389–392. doi: 10.1016/0014-2999(81)90490-8. [DOI] [PubMed] [Google Scholar]
  3. Bousquet P., Guertzenstein P. G. Localization of the central cardiovascular action of clonidine. Br J Pharmacol. 1973 Dec;49(4):573–579. doi: 10.1111/j.1476-5381.1973.tb08532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Connor H. E., Drew G. M., Finch L., Hicks P. E. Pharmacological characteristics of spinal alpha-adrenoreceptors in rats. J Auton Pharmacol. 1981 Mar;1(2):149–156. doi: 10.1111/j.1474-8673.1981.tb00507.x. [DOI] [PubMed] [Google Scholar]
  5. Elghozi J. L., Head G. A., Wolf W. A., Anderson C. R., Korner P. I. Importance of spinal noradrenergic pathways in cardiovascular reflexes and central actions of clonidine and alpha-methyldopa in the rabbit. Brain Res. 1989 Oct 9;499(1):39–52. doi: 10.1016/0006-8993(89)91133-5. [DOI] [PubMed] [Google Scholar]
  6. Gustin M. P., Cerutti C., Paultre C. Z. Heterogeneous computer network for real-time hemodynamic signal processing. Comput Biol Med. 1990;20(3):205–215. doi: 10.1016/0010-4825(90)90006-b. [DOI] [PubMed] [Google Scholar]
  7. Head G. A. Cardiovascular functions of central noradrenergic neurons in rabbits. Clin Exp Pharmacol Physiol. 1991 Jan;18(1):51–54. doi: 10.1111/j.1440-1681.1991.tb01377.x. [DOI] [PubMed] [Google Scholar]
  8. Jarrott B., Conway E. L., Maccarrone C., Lewis S. J. Clonidine: understanding its disposition, sites and mechanism of action. Clin Exp Pharmacol Physiol. 1987 May;14(5):471–479. doi: 10.1111/j.1440-1681.1987.tb00999.x. [DOI] [PubMed] [Google Scholar]
  9. Klevans L. R., Kepner K., Kovacs J. L. Role of forebrain in clonidine-induced suppression of cardiovascular responses. Eur J Pharmacol. 1973 Nov;24(2):262–265. doi: 10.1016/0014-2999(73)90081-2. [DOI] [PubMed] [Google Scholar]
  10. Laubie M., Poignant J. C., Scuvée-Moreau J., Dabire H., Dresse A., Schmitt H. Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. J Pharmacol. 1985 Jul-Sep;16(3):259–278. [PubMed] [Google Scholar]
  11. Matsukawa K., Ninomiya I. Anesthetic effects on tonic and reflex renal sympathetic nerve activity in awake cats. Am J Physiol. 1989 Feb;256(2 Pt 2):R371–R378. doi: 10.1152/ajpregu.1989.256.2.R371. [DOI] [PubMed] [Google Scholar]
  12. Murthy V. S., Zagar M. E., Vollmer R. R., Schmidt D. H. Pentobarbital-induced changes in vagal tone and reflex vagal activity in rabbits. Eur J Pharmacol. 1982 Oct 15;84(1-2):41–50. doi: 10.1016/0014-2999(82)90155-8. [DOI] [PubMed] [Google Scholar]
  13. Palaić D., Page I. H., Khairallah P. A. Uptake and metabolism of [14C] serotonin in rat brain. J Neurochem. 1967 Jan;14(1):63–69. doi: 10.1111/j.1471-4159.1967.tb09494.x. [DOI] [PubMed] [Google Scholar]
  14. Punnen S., Urbanski R., Krieger A. J., Sapru H. N. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 1987 Oct 6;422(2):336–346. doi: 10.1016/0006-8993(87)90941-3. [DOI] [PubMed] [Google Scholar]
  15. Sannajust F., Cerutti C., Koenig-Bérard E., Sassard J. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol. 1992 Mar;105(3):542–548. doi: 10.1111/j.1476-5381.1992.tb09016.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sannajust F., Julien C., Barrès C., Cerutti C., Koenig-Bérard E., Sassard J. Cardiovascular effects of rilmenidine, a new alpha 2-adrenoceptor agonist, and clonidine in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1989 Nov;16(11):837–848. doi: 10.1111/j.1440-1681.1989.tb01523.x. [DOI] [PubMed] [Google Scholar]
  17. Schramm L. P., Chornoboy E. S. Sympathetic activity in spontaneously hypertensive rats after spinal transection. Am J Physiol. 1982 Nov;243(5):R506–R511. doi: 10.1152/ajpregu.1982.243.5.R506. [DOI] [PubMed] [Google Scholar]
  18. Schramm L. P., Livingstone R. H. Inhibition of renal nerve sympathetic activity by spinal stimulation in rat. Am J Physiol. 1987 Mar;252(3 Pt 2):R514–R525. doi: 10.1152/ajpregu.1987.252.3.R514. [DOI] [PubMed] [Google Scholar]
  19. Solomon R. E., Brody M. J., Gebhart G. F. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine. J Pharmacol Exp Ther. 1989 Oct;251(1):27–38. [PubMed] [Google Scholar]
  20. Taylor R. F., Schramm L. P. Differential effects of spinal transection on sympathetic nerve activities in rats. Am J Physiol. 1987 Oct;253(4 Pt 2):R611–R618. doi: 10.1152/ajpregu.1987.253.4.R611. [DOI] [PubMed] [Google Scholar]
  21. Thorén P., Ricksten S. E. Recordings of renal and splanchnic sympathetic nervous activity in normotensive and spontaneously hypertensive rats. Clin Sci (Lond) 1979 Dec;57 (Suppl 5):197s–199s. doi: 10.1042/cs057197s. [DOI] [PubMed] [Google Scholar]
  22. Timmermans P. B., Schoop A. M., Kwa H. Y., Van Zwieten P. A. Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur J Pharmacol. 1981 Mar 5;70(1):7–15. doi: 10.1016/0014-2999(81)90426-x. [DOI] [PubMed] [Google Scholar]
  23. Van Zwieten P. A. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine. Am J Cardiol. 1988 Feb 24;61(7):6D–14D. doi: 10.1016/0002-9149(88)90457-2. [DOI] [PubMed] [Google Scholar]
  24. Zimpfer M., Manders W. T., Barger A. C., Vatner S. F. Pentobarbital alters compensatory neural and humoral mechanisms in response to hemorrhage. Am J Physiol. 1982 Nov;243(5):H713–H721. doi: 10.1152/ajpheart.1982.243.5.H713. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES